Socialism/Fascism is the main problem in the U.S : In Re Epipen

[Norman]

The article perfectly highlights why "donating" to Hillary is so profitable.

 

[Norman]

I wouldn't even want to live in this country if it wasn't for regulations, laws and investment from the government. The food, water and business environment would be controlled by the mafia.

Nah, actually you wouldn't want to live in this country if the government didn't provide you a lucrative, useless job, paid by tax dollars. You are part of the problem.

 

[Timmy]

The epipen is 1/2 the price is socialist medicine Canada.

Amazing how right wing kooks will bend reality to blame liberals .

 

[owebo]

The epipen is 1/2 the price is socialist medicine Canada.

Amazing how right wing kooks will bend reality to blame liberals .

Newsflash Timmy: you're a fascist, like them....

 

[Contumacious]

Mylan CEO to Be Grilled by Congress Over EpiPen Price Surge


But the ones that need to be grilled are the scumbag congresscritters who refuse to abolish the FDA



__------------------_________----------



The Lack of EpiPen Competitors is the FDA's Fault

There’s a new bout of outrage over an expensive medicine or medical treatment. While the good in question changes each time, the blame always seems to fall on greedy corporations who just aren’t regulated enough. Free markets and capitalism are the scapegoat, even when nothing remotely resembling unhampered markets in health care is in place in the United States.

EpiPen is sold by Mylan, and the price for a pack of two has increased from about $100 in 2007 to over $600 as of May 2016. Mylan has tried to quell the storm by pointing out that many of their customers pay nothing for the drug because of insurance. Their deflection has been unsuccessful.

The economist looks for competitors in cases like this. A firm cannot just willy-nilly raise their prices without a competing firm leaping in to give consumers what they want at a lower price. As it turns out, Mylan has a great friend who keeps would-be competitors out of the market, or at least makes it so difficult for them that they eventually go out of business. That friend is the FDA.

Epinephrine is extremely cheap—just a few cents per dose. The complications come from producing the easy auto-injecting devices. Mylan “owns” their auto-injector device design, so competitors must find work-arounds in their devices to deliver the epinephrine into the patient’s body. This task, coupled with the tangled mess of FDA red tape, has proven to be difficult for would-be EpiPen competitors. It’s like expecting somebody to come up with a new way to play baseball without bases, balls, gloves, or bats, but still getting the game approved by the MLB as a baseball game substitute.

A French pharmaceutical company offered an electronic device that actually talks people through the steps of administering the drug, but it was recalled because of concerns about it delivering the required dose. Just this year, Teva Pharmaceutical’s attempt at bringing a generic epinephrine injector to market in the US was blocked by the FDA. Adrenaclick and Twinject were unable to get insurance companies on board and so discontinuedtheir injectors in 2012.


.